Consumer Price Differentials Between Generic and Brand Name Prescriptions.

American Journal of Public Health - United States
doi 10.2105/ajph.64.10.977
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Public Health Association

Related search

Generic Scrip Share and the Price of Brand-Name Drugs: The Role of the Consumer

2005English

Brand-Name Versus Generic: The Authors Respond

Health Affairs
MedicineHealth Policy
2007English

Consumer Choice Between Common Generic and Brand Medicines in a Country With a Small Generic Market

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2015English

The Concept Of: Generic Drugs and Patented Drugs vs. Brand Name Drugs and Non-Proprietary (Generic) Name Drugs

Frontiers in Pharmacology
Pharmacology
2013English

Brand Name or Generic Drugs: A National Survey of Patient Perception and Preferences

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Role of County-Level Socioeconomic Status on Brand-Name Prescriptions in Medicare Part D

Medicine
Medicine
2020English

Emotional Connect Between Brand and Consumer Through Sensory Branding

American Journal of Industrial and Business Management
2017English

Generic Selection Criteria for Safety and Patient Benefit [VIII]: Comparing the Physicochemical and Pharmaceutical Properties of Brand-Name and Generic Diclofenac Sodium Tapes

Drug discoveries & therapeutics
MedicineToxicologyPharmaceuticsPharmacology
2019English

Agent Intermediation and Racial Price Differentials

SSRN Electronic Journal
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy